PuraPly™ Antimicrobial Wound Matrix

DEVICE3 trials

Sponsors

Organogenesis

Conditions

Chronic Vascular UlcerDiabetic UlcerDiabetic UlcersDraining WoundsPartial Thickness WoundPressure UlcerPressure UlcersSurgical Wound

Unknown Phase

Prospective PuraPly™ AM Case Series Study

CompletedNCT03070925

OrganogenesisDiabetic Ulcers, Pressure Ulcers, Surgical Wounds +2

Start: 2016-11-30End: 2017-05-31Updated: 2017-08-31

PuraPly™ Antimicrobial Wound Matrix and Wound Management

CompletedNCT03070938

OrganogenesisDiabetic Ulcer, Pressure Ulcer, Surgical Wound +2

Start: 2016-11-30End: 2017-10-31Updated: 2017-11-06

The RESPOND Registry

CompletedNCT03286452

OrganogenesisChronic Vascular Ulcer, Diabetic Ulcer, Draining Wounds +5

Start: 2017-02-21End: 2019-01-26Updated: 2019-02-27

Related Papers

Type I collagen matrix plus polyhexamethylene biguanide antimicrobial for the treatment of cutaneous wounds

Journal of Comparative Effectiveness Research2020-06-0118 citations